You are here

Home > Media and events >

Media releases

Released in 2017

July 24
SQI Partners with McMaster to co-develop “instant immunoassay” testing technology
July 18
SQI DIAGNOSTICS ANNOUNCES COMMERCIAL CONTRACT WITH GLOBAL BIOTECHNOLOGY COMPANY
July 13
DR. JAYMIE SAWYER, VICE PRESIDENT OF R&D, TRANSITIONS TO LEAD SCIENTIFIC ADVISORY COMMITTEE
July 6
SQI Sells Sqid-X System to IRX Therapeutics
May 10
SQI Diagnostics Reports Second Quarter 2017 Results
May 3
SQI Diagnostics to Announce Second Quarter 2017 Results
May 1
SQI DIAGNOSTICS TO EXHIBIT AT THE NATIONAL BIOTECHNOLOGY CONFERENCE
April 27
SQI DIAGNOSTICS TO PRESENT AT BLOOM BURTON HEALTHCARE INVESTOR CONFERENCE
March 27
SQI Diagnostics signs agreement to partner on revolutionary cardiac event prediction test
March 15
SQI Diagnostics Announces Stock Option Grant
March 10
SQI Diagnostics Inc. Closes Upsized Private Placement with Insider Participation
March 6
SQI Diagnostics Inc. Announces Private Placement with Insider Participation
February 21
SQI Diagnostics Reports First Quarter 2017 Results
February 13
SQI Diagnostics to Announce First Quarter 2017 Results
January 18
SQI DIAGNOSTICS ANNOUNCES CHANGE TO ITS BOARD OF DIRECTORS
January 12
SQI Diagnostics to Extend Warrant Expiry

Released in 2016

December 6
SQI Diagnostics Reports Fourth Quarter and Fiscal 2016 Results
November 23
SQI Diagnostics to Announce Fourth Quarter and Fiscal 2016 Results
September 12
SQI Sells Second sqidlite™-DH System to Diagnostics Segment Customer
August 30
SQI Sells Sqidlite System to Global Pharmaceutical Customer
August 19
SQI Diagnostics Inc. Announces Closing of Rights Offering
August 18
SQI Diagnostics Reports Third Quarter 2016 Results
August 2
SQI Diagnostics to Announce Third Quarter 2016 Results
July 19
SQI Diagnostics accelerates transformation from an R&D company to a recurring revenue company
July 14
SQI Diagnostics Inc. Announces Rights Offering
May 13
SQI Diagnostics Reports Second Quarter 2016 Results
April 29
SQI Diagnostics to Announce Second Quarter 2016 Results
April 18
Allergan to Highlight SQI Diagnostics' Technology at 10th WRIB Conference
March 29
SQI Sells Sqidlite™-dh System to a Major Diagnostics Customer
March 16
SQI Diagnostics Announces Stock Option Grant
March 11
SQI Diagnostics to Extend Warrant Expiry
February 17
SQI Diagnostics Announces Management Changes
February 11
SQI Diagnostics Reports First Quarter 2016 Results
February 4
SQI Diagnostics to Announce First Quarter 2016 Results
January 14
SQI Diagnostics to Extend Warrant Expiry

Released in 2015

December 21
SQI Diagnostics Inc. Announces Additional Closing of Private Placement
December 16
SQI Diagnostics Reports Fourth Quarter and Fiscal 2015 Results
December 15
SQI Diagnostics Inc. Announces Closing of Private Placement
December 10
SQI Diagnostics to Announce Fourth Quarter and Fiscal 2015 Results
December 1
SQI Diagnostics Inc. Announces Private Placement with Insider Participation
October 22
SQI DIAGNOSTICS FORMALIZES MULTIPLE CONTRACTS WITH GLOBAL PHARMACEUTICAL FIRM
September 18
SQI Diagnostics Announces Stock Option Grant
August 18
SQI Diagnostics Reports Third Quarter Financial Results
August 10
SQI Diagnostics to Announce Third Quarter 2015 Results
July 16
SQI Diagnostics Inc. Announces Closing of Private Placement
June 22
SQI Diagnostics Inc. Announces Private Placement with Insider Participation
May 21
SQI Diagnostics Reports Second Quarter Financial Results
May 14
SQI Diagnostics to Announce Second Quarter 2015 Results
April 17
SQI Diagnostics to Extend Warrant Expiry
April 15
SQI Delivers Sqidlite System to Global Pharmaceutical Customer
April 9
Bristol-Myers Squibb to Highlight SQI's Technology at WRIB Conference
April 8
SQI Announces Election of Directors
March 26
SQI DIAGNOSTICS INC. ANNOUNCES ADJOURNMENT OF MEETING
March 25
SQI DIAGNOSTICS INC. ANNOUNCES NEW NOMINEES TO SQI DIAGNOSTICS BOARD AND ADJOURNMENT OF MEETING
March 3
SQI Diagnostics Appoints Chief Financial Officer
February 26
SQI Diagnostics Reports First Quarter Financial Results
February 20
SQI Diagnostics Completes Final Tranche of Debenture Financing
February 19
SQI Diagnostics to Announce First Quarter 2015 Results
January 30
SQI Diagnostics Completes Tranche of Debenture Financing
January 21
SQI Diagnostics Announces Debt Financing of up to $4 Million

Released in 2014

December 17
SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
December 15
SQI Diagnostics Wins Additional Business from UK-based Customer
December 10
SQI Diagnostics to Announce Fourth Quarter and Fiscal 2014 Results
November 24
SQI DIAGNOSTICS Advances Commercial Opportunity with Leading Global Pharmaceutical Customer
November 7
SQI DIAGNOSTICS Receives FDA Clearance for its Ig_plex Celiac DGP Panel for Sale in the United States
October 16
SQI DIAGNOSTICS TO PRESENT AT THE 15th ANNUAL IMMUNOGENICITY FOR BIOTHERAPEUTICS CONFERENCE
September 29
SQI DIAGNOSTICS ANNOUNCES NEW CHAIRMAN OF BOARD OF DIRECTORS
September 17
SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States
August 22
SQI Diagnostics Contracted to Automate Pathogen Detection Assays
August 18
SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost
August 6
SQI Diagnostics Reports Fiscal Third Quarter Results
July 15
SQI Diagnostics Appoints Industry Veteran to its Board of Directors
May 20
SQI Diagnostics Hired by Global Pharmaceutical Company to Develop Two Prototype Multiplex Immunoassays for Evaluation
May 12
SQI Records First Revenues from Sales to Global Pharmaceutical Customers
April 10
SQI Diagnostics Completes $4.2 Million Equity Financing
April 4
SQI Diagnostics Files Final Prospectus for Equity Financing
March 19
SQI Diagnostics Signs Commercial Agreement with Global Pharma Customer
March 12
SQI Diagnostics Announces Filing of Preliminary Prospectus
February 24
SQI Diagnostics Receives Health Canada Medical Device License for its Celiac Test Kit
February 14
SQI Diagnostics Reports First Quarter Financial Results
January 28
SQI Diagnostics Reports Fourth Quarter and Annual Financial Results
January 27
SQI Announces Closing of Private Placement

Released in 2013

December 18
SQI Diagnostics Wins Commercial Agreement with Global Pharma
November 28
SQI Diagnostics to Extend Warrant Expiry
October 31
SQI Diagnostics Announces Agreement with Isis Pharmaceuticals
October 15
SQI Diagnostics to Extend Warrant Expiry
October 8
Bristol-Myers Squibb Presentation And Poster To Highlight SQI's Technology
September 30
SQI Diagnostics Announces Changes To Its Board Of Directors
August 26
SQI Diagnostics Reports Third Quarter Financial Results
July 30
SQI Diagnostics Provides Update on Commercial Milestones with Multiple Global Pharma Projects
July 29
SQI Diagnostics to Extend Warrant Expiry Date
June 3
SQI Diagnostics Announces Executive Promotions
May 21
SQI Diagnostics Reports Second Quarter Financial Results
May 3
SQI Announces Closing Of Private Placement
April 30
SQI Announces Private Placement Of Up To Cdn $3.760 Million
March 25
SQI Diagnostics and Algorithme Pharma Provide Update on Multiplex Heparin Immunogenicity Assay
February 14
SQI Diagnostics Reports First Quarter Financial Results
January 24
SQI Diagnostics and Algorithme Pharma to Develop Multiplex Heparin Immunogenicity Assay
January 10
SQI Diagnostics Announces Stock Option Grants

Released in 2012

December 13
SQI Diagnostics Reports Fourth Quarter and Annual Financial Results
December 3
SQI Diagnostics to Extend Warrant Expiry Date
November 19
SQI Diagnostics Exploring Strategic Alternatives to Maximize Growth and Shareholder Value